Literature DB >> 21514691

Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer's disease.

Lisa Mosconi1, Wai Tsui, John Murray, Pauline McHugh, Yi Li, Schantel Williams, Elizabeth Pirraglia, Lidia Glodzik, Susan De Santi, Shankar Vallabhajosula, Mony J de Leon.   

Abstract

Cognitively normal (NL) individuals with a maternal history of late-onset Alzheimer's disease (MH) show reduced brain glucose metabolism on FDG-PET as compared to those with a paternal history (PH) and those with negative family history (NH) of Alzheimer's disease (AD). This FDG-PET study investigates whether metabolic deficits in NL MH are associated with advancing maternal age at birth. Ninety-six NL individuals with FDG-PET were examined, including 36 MH, 24 PH, and 36 NH. Regional-to-whole brain gray matter standardized FDG uptake value ratios were examined for associations with parental age across groups using automated regions-of-interest and statistical parametric mapping. Groups were comparable for clinical and neuropsychological measures. Brain metabolism in AD-vulnerable regions was lower in MH compared to NH and PH, and negatively correlated with maternal age at birth only in MH. There were no associations between paternal age and metabolism in any group. Evidence for a maternally inherited, maternal age-related mechanism provides further insight on risk factors and genetic transmission in late-onset AD. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21514691      PMCID: PMC3155000          DOI: 10.1016/j.neurobiolaging.2011.03.003

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  43 in total

1.  Hippocampal hypometabolism predicts cognitive decline from normal aging.

Authors:  Lisa Mosconi; Susan De Santi; Juan Li; Wai Hon Tsui; Yi Li; Madhu Boppana; Eugene Laska; Henry Rusinek; Mony J de Leon
Journal:  Neurobiol Aging       Date:  2007-01-11       Impact factor: 4.673

2.  Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's.

Authors:  Lisa Mosconi; Lidia Glodzik; Rachel Mistur; Pauline McHugh; Kenneth E Rich; Elizabeth Javier; Schantel Williams; Elizabeth Pirraglia; Susan De Santi; Pankaj D Mehta; Raymond Zinkowski; Kaj Blennow; Domenico Pratico; Mony J de Leon
Journal:  Biol Psychiatry       Date:  2010-11-15       Impact factor: 13.382

3.  Advancing paternal age and the risk of schizophrenia.

Authors:  D Malaspina; S Harlap; S Fennig; D Heiman; D Nahon; D Feldman; E S Susser
Journal:  Arch Gen Psychiatry       Date:  2001-04

4.  The epidemiology of mental retardation of unknown cause.

Authors:  L A Croen; J K Grether; S Selvin
Journal:  Pediatrics       Date:  2001-06       Impact factor: 7.124

Review 5.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

6.  Variability of age at onset in siblings with familial Alzheimer disease.

Authors:  Estrella Gómez-Tortosa; M Sagrario Barquero; Manuel Barón; M Jose Sainz; Sagrario Manzano; Maria Payno; Raquel Ros; Carmen Almaraz; Pilar Gómez-Garré; Adriano Jiménez-Escrig
Journal:  Arch Neurol       Date:  2007-12

7.  Fertility and parental age in Alzheimer disease.

Authors:  J A White; M McGue; L L Heston
Journal:  J Gerontol       Date:  1986-01

8.  Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease.

Authors:  R A Honea; R H Swerdlow; E D Vidoni; J Goodwin; J M Burns
Journal:  Neurology       Date:  2010-01-12       Impact factor: 9.910

9.  Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease.

Authors:  L Mosconi; R Mistur; R Switalski; M Brys; L Glodzik; K Rich; E Pirraglia; W Tsui; S De Santi; M J de Leon
Journal:  Neurology       Date:  2008-11-12       Impact factor: 9.910

10.  Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease.

Authors:  Yi Li; Juha O Rinne; Lisa Mosconi; Elizabeth Pirraglia; Henry Rusinek; Susan DeSanti; Nina Kemppainen; Kjell Någren; Byeong-Chae Kim; Wai Tsui; Mony J de Leon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-06-20       Impact factor: 9.236

View more
  6 in total

1.  Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies.

Authors:  Lisa Mosconi
Journal:  Clin Transl Imaging       Date:  2013-08

2.  Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex.

Authors:  Kelly M Bakulski; Dana C Dolinoy; Maureen A Sartor; Henry L Paulson; John R Konen; Andrew P Lieberman; Roger L Albin; Howard Hu; Laura S Rozek
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 3.  Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions.

Authors:  Jia Yao; Jamaica R Rettberg; Lauren P Klosinski; Enrique Cadenas; Roberta Diaz Brinton
Journal:  Mol Aspects Med       Date:  2011-10-21

Review 4.  Family history and APOE-4 genetic risk in Alzheimer's disease.

Authors:  Markus Donix; Gary W Small; Susan Y Bookheimer
Journal:  Neuropsychol Rev       Date:  2012-02-23       Impact factor: 7.444

Review 5.  Beyond amyloid: Immune, cerebrovascular, and metabolic contributions to Alzheimer disease in people with Down syndrome.

Authors:  Alessandra C Martini; Thomas J Gross; Elizabeth Head; Mark Mapstone
Journal:  Neuron       Date:  2022-04-25       Impact factor: 18.688

6.  Periodontal disease associates with higher brain amyloid load in normal elderly.

Authors:  Angela R Kamer; Elizabeth Pirraglia; Wai Tsui; Henry Rusinek; Shankar Vallabhajosula; Lisa Mosconi; Li Yi; Pauline McHugh; Ronald G Craig; Spencer Svetcov; Ross Linker; Chen Shi; Lidia Glodzik; Schantel Williams; Patricia Corby; Deepak Saxena; Mony J de Leon
Journal:  Neurobiol Aging       Date:  2014-11-05       Impact factor: 4.673

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.